Market Growth Driven by Advancements in Genomic Research, Rising Demand for Personalized Medicine, and Key Applications in ...

Results from a new University of Kentucky Markey Cancer Center study show that molecular tumor boards can play an important ...

The organisms found in the microbiome outnumber human cells. This makes the microbiome a key target to aid in our ...

Following a CURE® Educated Patient® Lung Cancer Summit, the City of Hope expert answered 10 commonly asked questions from ...

Metagenomic sequencing uses next generation sequencing (NGS) to rapidly identify and analyze microbial community diversity and understand the role of constituent species. Our proprietary microbial ...

The agreement for the use of NuProbe’s NGS panel will support the accelerated development of Angle’s pan-cancer assay.

Most patients with advanced prostate cancer or urothelial cancer are not undergoing next-generation sequencing, a new study suggests.

In the rapidly evolving field of genomics, a new class of non-coding RNAs has captured the attention of researchers worldwide - circular RNAs (circRNAs). Unlike their linear counterparts, circRNAs are ...

Refurbished DNA Sequencing platform Market. Refurbished DNA Sequencing Platform market – Comprehensive Study with focus on key drivers, trends, methodolo ...

ANGLE plc has signed an agreement with NuProbe USA to use its pan-cancer next generation sequencing panel. NuProbe has granted ANGLE plc an option for an exclusive global license to the NGS panel ...

Burning Rock Biotech Limited (NASDAQ: BNR) (the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, ...

CleanNGS Dx is CleanNA’s third CE-IVD compliant product launched over the course of a year, after the Clean Cell Free DNA Kit (CE-IVD) and Clean Quick Viral DNA/RNA (CE-IVD). The Dutch company is ...